Dimerix

Dimerix Net Tangible Assets

The Net Tangible Assets of Dimerix (DXB.AX) as of Oct 11, 2026 is -14.76 M AUD. In the previous year, Net Tangible Assets was 13.38 M AUD — a change of -210.30% (lower).

Net Tangible Assets

-14.76 MAUD

YoY

-210.30%

Last updated:

Net Tangible Assets of Dimerix is 2026 -14.76 M AUD. Net Tangible Assets of Dimerix was 2025 13.38 M AUD. It decreases by -210.30% lower compared to the previous year.

The Dimerix Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2019
4.20 M AUD
Jan 1, 2020
7.76 M AUD
Jan 1, 2021
1.47 M AUD
Jan 1, 2022
14.42 M AUD
Jan 1, 2023
5.96 M AUD
Jan 1, 2024
18.19 M AUD
Jan 1, 2025
13.38 M AUD
Jan 1, 2026
-14.76 M AUD
The Dimerix Net Tangible Assets history
YEARNet Tangible AssetsYoY
-14.76 MAUD-210.30%
13.38 MAUD-26.43%
18.19 MAUD+204.97%
5.96 MAUD-58.65%
14.42 MAUD+882.13%
1.47 MAUD-81.07%
7.76 MAUD+84.62%
4.20 MAUD-38.72%
6.86 MAUD+160.79%
2.63 MAUD+17.26%
2.24 MAUD-19.25%
2.78 MAUD+8,796.37%
31,216.00AUD—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Net Tangible Assets of Dimerix is -14.76 M AUD in 2026.

Net Tangible Assets of Dimerix changed from 13.38 M AUD to -14.76 M AUD, representing a -210.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Dimerix since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Dimerix historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Dimerix

All Key Metrics — Dimerix